Helping to deliver effective vaccines

Dr Odile Leroy, Executive Director of the EVI and coordinator of TRANSVAC2 said:

“The TRANSVAC2 activities will further strengthen the vaccine R&D infrastructure in Europe and accelerate the development of effective vaccines that are urgently needed to address global health challenges”

Dr Mei Mei Ho from the Division of Bacteriology at NIBSC, adds:

"With our experience NIBSC will contribute to several key activities, including assay development, and provide our scientific and technical expertise through networking opportunities."

For more information on TRANSVAC2 visit the European Vaccine Initiative’s website.